Cited 0 times in
Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 성백린 | - |
dc.date.accessioned | 2023-06-02T00:52:48Z | - |
dc.date.available | 2023-06-02T00:52:48Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 0042-6822 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194489 | - |
dc.description.abstract | Annual repeat influenza vaccination raises concerns about protective efficacy against mismatched viruses. We investigated the impact of heterologous prime-boost vaccination on inducing cross protection by designing recombinant influenza viruses with chimeric hemagglutinin (HA) carrying M2 extracellular domains (M2e-HA). Heterologous prime-boost vaccination of C57BL/6 mice with M2e-HA chimeric virus more effectively induced M2e and HA stalk specific IgG antibodies correlating with cross protection than homologous prime-boost vaccination. Induction of M2e and HA stalk specific IgG antibodies was compromised in 1-year old mice, indicating significant aging effects on priming subdominant M2e and HA stalk IgG antibody responses. This study demonstrates that a heterologous prime-boost strategy with recombinant influenza virus expressing extra M2e epitopes provides more effective cross protection than homologous vaccination. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Academic Press | - |
dc.relation.isPartOf | VIROLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Age Factors | - |
dc.subject.MESH | Aging / genetics | - |
dc.subject.MESH | Aging / immunology* | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antibodies, Viral / biosynthesis* | - |
dc.subject.MESH | Antigens, Viral / genetics | - |
dc.subject.MESH | Antigens, Viral / immunology | - |
dc.subject.MESH | Cross Protection | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Hemagglutinin Glycoproteins, Influenza Virus / genetics* | - |
dc.subject.MESH | Hemagglutinin Glycoproteins, Influenza Virus / immunology | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunization, Secondary / methods | - |
dc.subject.MESH | Immunogenicity, Vaccine | - |
dc.subject.MESH | Immunoglobulin G / biosynthesis* | - |
dc.subject.MESH | Influenza A Virus, H1N1 Subtype / immunology | - |
dc.subject.MESH | Influenza A Virus, H1N1 Subtype / pathogenicity | - |
dc.subject.MESH | Influenza A Virus, H3N2 Subtype / immunology | - |
dc.subject.MESH | Influenza A Virus, H3N2 Subtype / pathogenicity | - |
dc.subject.MESH | Influenza Vaccines / administration & dosage | - |
dc.subject.MESH | Influenza Vaccines / biosynthesis | - |
dc.subject.MESH | Influenza Vaccines / genetics* | - |
dc.subject.MESH | Influenza, Human / immunology | - |
dc.subject.MESH | Influenza, Human / prevention & control* | - |
dc.subject.MESH | Influenza, Human / virology | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred C57BL | - |
dc.subject.MESH | Models, Molecular | - |
dc.subject.MESH | Orthomyxoviridae Infections / immunology | - |
dc.subject.MESH | Orthomyxoviridae Infections / prevention & control* | - |
dc.subject.MESH | Orthomyxoviridae Infections / virology | - |
dc.subject.MESH | Recombinant Fusion Proteins / chemistry | - |
dc.subject.MESH | Recombinant Fusion Proteins / genetics | - |
dc.subject.MESH | Recombinant Fusion Proteins / immunology | - |
dc.subject.MESH | Vaccination / methods | - |
dc.subject.MESH | Vaccines, Synthetic | - |
dc.subject.MESH | Viral Matrix Proteins / genetics | - |
dc.subject.MESH | Viral Matrix Proteins / immunology | - |
dc.title | Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Microbiology (미생물학교실) | - |
dc.contributor.googleauthor | Bo Ryoung Park | - |
dc.contributor.googleauthor | Jeeva Subbiah | - |
dc.contributor.googleauthor | Ki-Hye Kim | - |
dc.contributor.googleauthor | Young-Man Kwon | - |
dc.contributor.googleauthor | Judy Oh | - |
dc.contributor.googleauthor | Min-Chul Kim | - |
dc.contributor.googleauthor | Chong-Hyun Shin | - |
dc.contributor.googleauthor | Baik Lin Seong | - |
dc.contributor.googleauthor | Sang-Moo Kang | - |
dc.identifier.doi | 10.1016/j.virol.2021.12.003 | - |
dc.contributor.localId | A06211 | - |
dc.relation.journalcode | J02785 | - |
dc.identifier.eissn | 1096-0341 | - |
dc.identifier.pmid | 34929590 | - |
dc.subject.keyword | Cross protection | - |
dc.subject.keyword | Live attenuated virus | - |
dc.subject.keyword | M2e | - |
dc.subject.keyword | Recombinant influenza virus | - |
dc.contributor.alternativeName | Seong, Baik L | - |
dc.contributor.affiliatedAuthor | 성백린 | - |
dc.citation.volume | 566 | - |
dc.citation.startPage | 143 | - |
dc.citation.endPage | 152 | - |
dc.identifier.bibliographicCitation | VIROLOGY, Vol.566 : 143-152, 2022-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.